CMMB
Price
$1.08
Change
-$0.05 (-4.42%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
20.29M
34 days until earnings call
SPRB
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
12.09M
33 days until earnings call
Ad is loading...

CMMB vs SPRB

Header iconCMMB vs SPRB Comparison
Open Charts CMMB vs SPRBBanner chart's image
Chemomab Therapeutics
Price$1.08
Change-$0.05 (-4.42%)
Volume$1K
Capitalization20.29M
Spruce Biosciences
Price$0.29
Change-$0.00 (-0.00%)
Volume$1.54K
Capitalization12.09M
CMMB vs SPRB Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. SPRB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and SPRB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CMMB: $1.13 vs. SPRB: $0.29)
Brand notoriety: CMMB and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 44% vs. SPRB: 137%
Market capitalization -- CMMB: $20.29M vs. SPRB: $12.09M
CMMB [@Biotechnology] is valued at $20.29M. SPRB’s [@Biotechnology] market capitalization is $12.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileSPRB’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • SPRB’s FA Score: 1 green, 4 red.
According to our system of comparison, CMMB is a better buy in the long-term than SPRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 4 TA indicator(s) are bullish while SPRB’s TA Score has 4 bullish TA indicator(s).

  • CMMB’s TA Score: 4 bullish, 4 bearish.
  • SPRB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CMMB is a better buy in the short-term than SPRB.

Price Growth

CMMB (@Biotechnology) experienced а -2.59% price change this week, while SPRB (@Biotechnology) price change was -8.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CMMB is expected to report earnings on May 08, 2025.

SPRB is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMMB($20.3M) has a higher market cap than SPRB($12.1M). SPRB YTD gains are higher at: -30.310 vs. CMMB (-37.569). CMMB has higher annual earnings (EBITDA): -15.37M vs. SPRB (-39.02M). SPRB has more cash in the bank: 60.1M vs. CMMB (19.4M). CMMB has less debt than SPRB: CMMB (342K) vs SPRB (3.23M). SPRB has higher revenues than CMMB: SPRB (7.1M) vs CMMB (0).
CMMBSPRBCMMB / SPRB
Capitalization20.3M12.1M168%
EBITDA-15.37M-39.02M39%
Gain YTD-37.569-30.310124%
P/E RatioN/AN/A-
Revenue07.1M-
Total Cash19.4M60.1M32%
Total Debt342K3.23M11%
FUNDAMENTALS RATINGS
CMMB: Fundamental Ratings
CMMB
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMMBSPRB
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 18 days ago
89%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MHLD0.610.04
+6.10%
Maiden Holdings Ltd
MBLY14.970.48
+3.31%
Mobileye Global
STBX0.19N/A
+2.10%
Starbox Group Holdings Ltd.
LLYVA70.391.20
+1.73%
Liberty Media Corp
ULCC4.32N/A
N/A
Frontier Group Holdings

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
+8.65%
AXON - CMMB
37%
Loosely correlated
+3.18%
SPRB - CMMB
36%
Loosely correlated
+9.21%
SYRE - CMMB
31%
Poorly correlated
+1.27%
OVID - CMMB
31%
Poorly correlated
+9.78%
DSGN - CMMB
30%
Poorly correlated
+5.13%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with IMRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then IMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-0.10%
IMRX - SPRB
52%
Loosely correlated
-3.85%
MLEC - SPRB
51%
Loosely correlated
-4.18%
CLRB - SPRB
45%
Loosely correlated
+0.41%
QTTB - SPRB
45%
Loosely correlated
+9.09%
SCPX - SPRB
43%
Loosely correlated
-3.26%
More